Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 1, 1995
Clinical reproducibility of dual energy x-ray absorptiometryP Williams-Russo, J H Healey, T P Szatrowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.The Journal of Bone and Joint Surgery. American Volume|December 1, 1992
Geographic variations in the rates of elective total hip and knee arthroplasties among Medicare beneficiaries in the United StatesM G Peterson, J P Hollenberg, T P Szatrowski, et al.Journal of Chronic Diseases|January 1, 1984
Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohortT P Szatrowski, A V Peterson, Y Shimizu, et al.Anesthesia and Analgesia|March 1, 1996
High reproducibility in the interpretation of intraoperative transesophageal echocardiographic evaluation of aortic atheromatous diseaseG S Hartman, J Peterson, S N Konstadt, et al.American Journal of Epidemiology|July 1, 1982
Serial blood pressure measurements and cardiovascular disease in a Japanese cohortR L Prentice, Y Shimizu, C H Lin, et al.Stroke|December 1, 1994
Cerebral emboli detected during bypass surgery are associated with clamp removalD Barbut, R B Hinton, T P Szatrowski, et al.Calcified Tissue International|February 1, 1996
A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumaticaJ H Healey, S A Paget, P Williams-Russo, et al.Blood|January 1, 1994
Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor-alpha and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanomaL M Minasian, T P Szatrowski, M Rosenblum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420E J Lee, S L George, M Caligiuri, et al.Pageof 3